Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Well, we will wait and see how Monic Stuart works out as the new CMO. Been reading up on her.
On one hand, previous to Marker she was at Geron who after 33 years MAY POSSIBLY get their first drug approved in 2024 (myelodysplastic syndrome MDS). Previous to that she was at Genentech and let's be honest, anything done with Genetech back then was caveman technology compared to current tech (RNAI, MRNA, CRISPR, CAR-T). I think Marker may want her more for FDA regulatory huddles and trials advancement than having her figuring out which new antigens to add to what compound mix.
On the other hand, as per Juan Vera: "Given Marker’s prioritization of the clinical program in acute myeloid leukemia (AML) and lymphoma, bringing on a CMO who is a transplant physician and has extensive experience in treating AML and lymphoma patients is a tremendous advantage in establishing our clinical strategy. Dr. Stuart’s impressive career both in industry and in the clinic as a treating physician will be key to enabling Marker to identify the optimal paths for advancing our programs targeting hematologic and solid tumors."
Let's hope he right.